MetaCap

Eloxx Pharmaceuticals Statistics

NASDAQ: ELOXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

10.69-0.19 (-1.75%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Eloxx Pharmaceuticals by the numbers

Eloxx Pharmaceuticals has a market capitalization of $43.7 million based on 4.09M shares outstanding. Its trailing P/E ratio is 5.6. The stock trades 23.8% below its 50-day average and 25.7% below its 200-day average.

Average daily trading volume is 28.48K shares, or about $304,398 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ELOX valuation vs. peer median

ELOX compared with the median of 8 peer companies
MetricELOXPeer medianDifference
Market cap$43.69M$46.57M-6%
Avg. volume28.48K164.29K-83%

Peer median across 8 companies: GRML, INKT, ELUT, IMA, TIL, AVXL, CGTX, OKYO.

Valuation

Price and trading

Previous close
10.88
Open
10.65
Day range
10.03 – 10.94
52-week range
8.20 – 23.40
Beta
—
Volume
14.98K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
43.69M
Pe
5.63
Forward Pe
-2.99
Eps
1.90
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
23.40
Week52 Low
8.20
Avg Volume
28,475.00
Shares Outstanding
4.09M
Ma50
14.02
Ma200
14.39
Earnings Date
Apr 2, 2025
Pct From52w High
-54.32%
Pct From52w Low
30.37%

Related